NCT03255798View on ClinicalTrials.gov

A Prospective Evaluation of Glaucoma Subjects Treated With Two Second Generation iStents and One iStent Supra

NATerminatedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

August 1, 2017

Primary Completion Date

June 6, 2019

Study Completion Date

June 6, 2019

Conditions
Glaucoma, Open-Angle
Interventions
DEVICE

G2 and G3

Two iStent inject devices and one iStent supra device

Trial Locations (1)

Unknown

Prof. Dr. med. Carl Erb, Berlin

Sponsors
All Listed Sponsors
lead

Glaukos Corporation

INDUSTRY

NCT03255798 - A Prospective Evaluation of Glaucoma Subjects Treated With Two Second Generation iStents and One iStent Supra | Biotech Hunter | Biotech Hunter